Hepatology

Eur Rev Med Pharmacol Sci 2023; 27 (16): 7607-7619
DOI: 10.26355/eurrev_202308_33413

A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocin

S.J. Alarfaj, M.M. Bahaa, H.A. Yassin, E. El-Khateeb, F.A. Kotkata, M.A. El-Gammal, A.I. Elberri, E. Habba, E.E. Zien El-Deen, M.O. Khrieba, T.A. El-Masry, W.A. Negm, E.I. Elberri
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (15): 7134-7147
DOI: 10.26355/eurrev_202308_33287

Neoadjuvant immunotherapy for resectable hepatocellular carcinoma: a systematic review and meta-analysis

Y.-H. Han, J.-Q. Bo, L.-X. Liu
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (14): 6530-6538
DOI: 10.26355/eurrev_202307_33123

Assessment of the diagnostic accuracy of noninvasive scoring tools in predicting moderate-to-severe steatohepatitis via ultrasonography in asymptomatic healthy subjects admitted to family medicine outpatient clinics

A. Mert
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (12): 5590-5595
DOI: 10.26355/eurrev_202306_32797

Serum biomarkers predictive of cirrhosis in alcoholic liver disease as an alternative to ARFI-SW elastography

R. Cioarca-Nedelcu, N.R. Kundnani, A. Sharma, D. Nistor, E. Maghet, V. Atanasiu, I. Stoian
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (10): 4536-4543
DOI: 10.26355/eurrev_202305_32460

LncRNA FOXD2-AS1 facilitates the progression of hepatocellular carcinoma by regulating TWIST1

G. Chen, W.-L. Zhang, S.-M. Zhang, K.-L. Tang, Y. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (9): 3833-3836
DOI: 10.26355/eurrev_202305_32288

A case of drug-induced myopathy in alcoholic cirrhosis caused by voriconazole

F. Su, X.-X. Meng, C.-Z. Su, J.-L. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (8): 3597-3611
DOI: 10.26355/eurrev_202304_32143

ABCC1 is a predictive biomarker for prognosis and therapy in hepatocellular carcinoma

Y.-H. Han, Y.-Q. Wang, J.-Q. Bo, Y.-N. Guo, Q.-Q. Zhang, L.-X. Liu
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (8): 3336-3343
DOI: 10.26355/eurrev_202304_32104

Acute kidney injury early after left ventricular assist device implantation: incidence, risk factors and clinical consequences

E. Gündüz
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (8): 3322-3335
DOI: 10.26355/eurrev_202304_32103

Vitamin C as a potential ameliorating agent against hepatotoxicity among alcoholic abusers

M.H. Al Garea, A.A. Alqasoumi, S.A. Alqahtani, A.H. Hadadi, A.M. Emara
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (6): 2706-2714
DOI: 10.26355/eurrev_202303_31809

Kidney dysfunction is associated with adverse outcomes in internal medicine COVID-19 hospitalized patients

S. Lai, A. Gigante, C. Pellicano, I. Mariani, F. Iannazzo, A. Concistrè, C. Letizia, M. Muscaritoli
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (6): 2277-2287
DOI: 10.26355/eurrev_202303_31761

Elucidation of the role of α-lipoic acid and vitamin C in methotrexate-induced hepatoxicity in mice

H.M. Al-kuraishy, R.R. Abd Hasan, A.I.A. Al-Gareeb, S.S. Aggad, A.S.M. Aljohani, I.M. El-Ashmawy, E. Elekhnawy, S.A. Mostafa, W.A. Negm, G.E. Batiha
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (5): 1921-1944
DOI: 10.26355/eurrev_202303_31558

Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance

E. Bellucci, F. Chiereghin, F. Pacifici, G. Donadel, A. De Stefano, G. Malatesta, M.G. Valente, F. Guadagni, M. Infante, V. Rovella, A. Noce, M. Tesauro, N. Di Daniele, D. Della Morte, D. Pastore
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (22): 8467-8480
DOI: 10.26355/eurrev_202211_30382

Delayed cervical cancer diagnosis: a systematic review

L. Allahqoli, T. Dehdari, A. Rahmani, A. Fallahi, M. Gharacheh, N. Hajinasab, H. Salehiniya, I. Alkatout
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (22): 8459-8466
DOI: 10.26355/eurrev_202211_30400

Biochemical predictors of hepatocellular cancer development after one year in patients who achieved HCV clearance by direct-acting antiviral treatment

Z.G. Sargin, I. Dusunceli
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (21): 7827-7832
DOI: 10.26355/eurrev_202211_30131

Awareness of chronic hepatitis C in the Western Black Sea Region

Z. Gok Sargin
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (20): 7533-7540
DOI: 10.26355/eurrev_202210_30024

Autoimmune hepatitis in monozygotic twins – a case report

K. Weiss, C.V. Sousa, B. Knechtle
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (20): 7522-7532
DOI: 10.26355/eurrev_202210_30023

Hepatoprotective effect of combination of L-carnitine and magnesium-hydroxide in nonalcoholic fatty liver disease patients: a double-blinded randomized controlled pilot study

R. Hazzan, N. Abu Ahmad, W. Slim, E. Mazen, Z. Neeman
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (19): 6990-6994
DOI: 10.26355/eurrev_202210_29882

Vessel sealing system vs. conventional knot-tying for hilar dissection during living donor hepatectomy: a prospective, randomized, double-blinded study

O. Gunes, S. Akbulut, A. Atay, F. Gonultas, A. Tuncer, A. Baskiran, S. Yilmaz
Free PDF Download